Skip Nav Destination
Article navigation
Meeting Abstracts|
September 1991
PHARMACOKINETICS OF INTERPLEURAL BUPIVACAINE IN PLASMA AND LUNG LYMPH
Anesthesiology Department, The University of Texas Medical Branch, Galveston, Texas 77550.
Anesthesiology September 1991, Vol. 75, A756.
Citation
V. Suresh, R. V. Johnston, D. L. Traber, L. D. Traber, J. F. Arens; PHARMACOKINETICS OF INTERPLEURAL BUPIVACAINE IN PLASMA AND LUNG LYMPH. Anesthesiology 1991; 75:A756 doi: https://doi.org/10.1097/00000542-199109001-00755
Download citation file:
Citing articles via
Most Viewed
Related Articles
Effect of ONO1714, a Specific Inducible Nitric Oxide Synthase Inhibitor, on Lung Lymph Filtration and Gas Exchange during Endotoxemia in Unanesthetized Sheep
Anesthesiology (July 2004)
Selective Thromboxane A 2 Synthase Inhibition by OKY-046 Prevents Cardiopulmonary Dysfunction after Ovine Smoke Inhalation Injury
Anesthesiology (May 2005)
Effects of Interpleural Bupivacaine on Respiratory Muscle Strength and Pulmonary Function
Anesthesiology (July 1995)
Intraperitoneal Versus Interpleural Morphine or Bupivacaine for Pain after Laparoscopic Cholecystectomy
Anesthesiology (March 1995)